Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about major depressive disorder Recent news which mentions major depressive disorder Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder June 20, 2024 Tickers NEWS Tags Cannabis Market News Beckley Psytech From Benzinga LSD Microdosing For Depression? This Clinical Study Reveals Promising Results February 26, 2024 Tickers NEWS Tags Benzinga Psychedelics News From Benzinga Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find November 01, 2023 Tickers CYBN Tags CYBN Psychedelic/Assisted Therapies Benzinga From Benzinga Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment October 03, 2023 Tickers CYBN Tags Penny Stocks News Cannabis From Benzinga Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results September 26, 2023 Tickers CYBN DMTTF Tags Benzinga Psychedelics DMT Clinical Trial From Benzinga Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression September 21, 2023 Tickers CYBN DMTTF Tags Psilocybin program Benzinga Psychedelics From Benzinga Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows September 03, 2023 Tags Psilocybin program Benzinga Psychedelics From Benzinga Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released May 09, 2023 Tickers CYBN Tags News Penny Stocks major depressive disorder From Benzinga 80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial April 17, 2023 Tickers MNMD Tags Penny Stocks Health Care Top Stories From Benzinga Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder April 14, 2023 Tickers CMPS Tags cancer Psilocybin/Assisted Therapy News From Benzinga DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial April 04, 2023 Tickers DMTTF Tags Psychedelics Benzinga DMTTF From Benzinga FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder March 23, 2023 Tickers HUGE Tags HUGE Benzinga Psychedelics From Benzinga Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable March 08, 2023 Tickers DMTTF Tags Cannabis Market News Markets From Benzinga Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results January 31, 2023 Tickers CMND Tags Psychedelics Benzinga Ketamine Treatment From Benzinga Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings January 25, 2023 Tickers DMTTF Tags SPL026 Psychedelics Benzinga From Benzinga This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage December 22, 2022 Tickers DMTTF Tags DMTTF News Penny Stocks From Benzinga Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing December 19, 2022 Tickers DMTTF Tags Penny Stocks clinical trials News From Benzinga FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder December 16, 2022 Tickers EHVVF Tags Management FDA Legal From Benzinga Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial October 13, 2022 Tickers RLMD Tags major depressive disorder why it's moving Market News From Benzinga Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close? September 14, 2022 Tickers MSSTF Tags Cannabis Market News Clinical Trial Authorization From Benzinga Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression August 30, 2022 Tickers CYBN Tags Success Stories Penny Stocks Health Care From Benzinga New Zealand Government Grants $650K For LSD Microdosing Trials July 25, 2022 Tickers BLRZF Tags Markets Cannabis NZ's Health Research Council (HRC) From Benzinga How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps April 29, 2022 Tags Psychedelics Benzinga PTSD From Benzinga Study Finds Psilocybin Anti-Depression Effects Last At Least One Year March 04, 2022 Tags Markets Psilocybin Market News From Benzinga Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients December 01, 2021 Tickers BIIB SAGE Tags General Phase 3 Trial Benzinga From Benzinga AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials October 29, 2021 Tickers ABBV Tags Benzinga Phase 3 Trial Biotech From Benzinga B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock October 21, 2021 Tickers SAGE SEEL Tags Briefs Price Target Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.